- 2025 adjusted EBITDA reached €1.87 billion, with sales decreasing by 7% to €14.1 billion.
- 2026 adjusted EBITDA is projected between €1.7 billion and €2.0 billion.
- Advanced Technologies revenue fell 2% to €5.97 billion, impacted by lower prices and currency effects.
- Custom Solutions revenue dropped 4% to €5.49 billion due to lower volumes and currency effects.
2025 Financial Performance
Evonik's 2025 adjusted EBITDA reached €1.87 billion, aligning with its forecast of around €1.9 billion. Sales decreased by 7% to €14.1 billion compared to the previous year. The cash conversion rate was 37%, supported by a free cash flow of €695 million. Net income rose to €265 million from €222 million in 2024.
2026 Outlook
For 2026, Evonik projects an adjusted EBITDA between €1.7 billion and €2.0 billion. The company plans to link the annual dividend to adjusted net income, distributing 40-60% to shareholders starting in 2026. For 2025, a dividend of €1.00 per share is proposed.
Segment Performance
In the Advanced Technologies segment, revenue fell 2% to €5.97 billion due to lower selling prices and negative currency effects, despite a slight increase in volumes. Adjusted EBITDA decreased by 8% to €944 million, with the margin dropping to 15.8% from 16.8%.
The Custom Solutions segment saw a 4% revenue decline to €5.49 billion, driven by lower volumes and currency effects, although selling prices rose slightly. Adjusted EBITDA was 7% lower at €909 million, with the margin falling to 16.6% from 17.0%.
Future Focus
Evonik aims for a return on capital employed (ROCE) of 11% in the medium term, with the 2025 figure at 6.1%, down from 7.1% in 2024.
